Rates of Sexually Transmitted Infection Diagnoses Among US Youth With Perinatally and Nonperinatally Acquired HIV. Issue 3 (28th March 2022)

• Record Type: Journal Article
• Authors: Neilan, Anne M.; DeMonte, Justin B.; Foote, Julia H. A.; Karalius, Brad; Patel, Kunjal; Kapogiannis, Bill G.; Rudy, Bret J.; Huszti, Heather; Fernandez, M. Isabel; Hudgens, Michael G.; Ciaranello, Andrea L.
• Is Part Of: Sexually transmitted diseases. Volume 49:Issue 3(2022)
• Page Start: 223
• Page End: 230
• Publication Date: 2022-03-28
• Subjects: Sexually transmitted diseases -- Periodicals; Sexual health -- Periodicals; 616.951005
• DOI: 10.1097/OLQ.0000000000001578
• Languages: English
• ISSNs: 0148-5717

Abstract

Abstract : Among youth with HIV in 3 Adolescent Medicine Trials Network for HIV/AIDS Interventions studies, youth with nonperinatal HIV spent less time on antiretroviral therapy and had higher rates of sexually transmitted infections compared with youth with perinatal HIV. Supplemental digital content is available in the text. Abstract : Background: Of new sexually transmitted infections (STIs) in the United States, 50% occur among youth aged 15 to 24 years. Previous studies among youth with HIV (YHIV) do not distinguish STI trends among individuals with perinatally (YPHIV) and nonperinatally (YNPHIV) acquired HIV. Methods: Among 3 Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) studies conducted between 2009 and 2015, we estimated incident diagnoses of trichomonal, bacterial, viral, and overall STIs stratified by sex assigned at birth, mode of HIV acquisition (perinatal [YPHIV] and nonperinatal [YNPHIV]), age (13–17 and 18–24 years), CD4 count (<200, 200–499, and ≥500/μL), and HIV viral load (VL) (<400 and ≥400 copies/mL). Results: Among 3131 YHIV, across the 3 studies, mean (SD) age was 20.6 (2.6) years, 888 (28%) were female, 2498 (80%) had nonperinatal HIV acquisition recorded, and 2298 (73%) were African American/Black. Mean follow-up was 0.9 (0.3) years. Compared with YPHIV, YNPHIV spent less person-time with VL <400 copies/mL (47% vs. 53%) and more time off antiretroviral therapy (49% vs. 15%), and had higher overall STI rates (males, 65.9 vs. 8.5/100 person-years [PY]; females, 54.7 vs. 17.2/100 PY). Among YPHIV, bacterial STIs were higher during person-time spent with VL ≥400 vs. <400 copies/mL (male YPHIV, 10.9 vs. 0.6/100 PY; female YPHIV, 11.2 vs. 2.9/100 PY); no difference was observed among YNPHIV, which may be due to concurrent acquisition of HIV and other STIs and limited follow-up. Conclusions: Compared with YPHIV, YNPHIV spent less time on antiretroviral therapy and virologically suppressed; YNPHIV also had higher STI diagnosis rates. Very high STI diagnosis rates among YHIV, including among those without virologic suppression, highlight the importance of youth-focused efforts to support durable virologic suppression and identify and treat STIs.